- Intestinal amebiasis:
- Adults: 500mg BD *5/7
- Children: 250mg BD *5/7
- Adjunct treatment in hepatic encephalopathy:
- PO 1g QID*5-6 days
Tablet:
- 250mg
Suspension:
- 125mg/5mL
- To be taken after a meal
Aminoglycoside.
It binds to bacterial 30S ribosomal subunit thereby inhibiting protein synthesis. It also suppresses urease producing bacteria consequently reducing ammonia absorption from gut
Minimal since it is not absorbed from the gut.
- Nausea
- Abdominal cramps
- Diarrhea
- Vomiting
- Heart burn
- Hypersensitivity to components
- Intestinal obstruction
- Cidofovir
Drug Status
| Availability | Prescription only |
| Pregnancy | Category C |
| Breastfeeding | Safe. It doesn’t enter breast milk. |
| Schedule | Not controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Biobrol | 125mg/5mL | Suspension | 60mL | Biodeal Labs | Biodeal Labs |
| Daboral | 250mg | Tablet | 20’s | Cosmos Ltd | Cosmos Ltd |
| Daboral | 125mg/5mL | Suspension | 60mL | Cosmos Ltd | Cosmos Ltd |
| Gabbroral | 250mg | Tablet | 12’s | Pfizer Labs | Pfizer Labs |
| Minodine | 250mg | Tablet | 20’s | Dawa Ltd | Dawa Ltd |
| Minodine | 125mg/5mL | Suspension | 60mL | Dawa Ltd | Dawa Ltd |
| Unibrol | 250mg | Tablet | 12’s, 24’s | Universal Corporation | Universal Corporation |
| Unibrol | 125mg/5mL | Suspension | 60mL | Universal Corporation | Universal Corporation |